Skip to main content

Table 1 Summary of changes of V-ATPase and neurodegenerative diseases

From: The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases

Gene

Diseases

Species/model

Pathological Mechanisms

Reference

V0a1

Alzheimer Disease

5 × FAD mice

decrease of N-glycosylation of V0a1

[176]

PS/APP mice

decrease of mature V0a1 in the lysosomal fraction

[181]

V0a2

Autosomal recessive cutis laxa typeII/Wrinkly Skin Syndrome

human

abnormal glycosylation of serum proteins (CDG-II) and impairment of Golgi trafficking by V0a2 mutation

[182,183,184,185]

V0a3

Autosomal recessive osteopetrosis with neurodegeneration

R444L mutant mice

endoplasmic reticulum retention and misprocessing of V0a3 due to R444L mutation

[186]

human

loss of V0a3 function due to truncation or impaired splicing caused by mutations

[187, 188]

V0a4

Renal Tubular Acidosis with hearing loss

human

mutations

[189]

V0a4−/− mice

proximal tubule dysfunction with defective endocytic trafficking and accumulation of lysosomal material with V0a4 knockout

[190, 191]

V1B1

Renal Tubular Acidosis with hearing loss

human

mutations

[189]

V1B2

Zimmermann-Laband syndrome

human

impaired complex assembly due to missense mutation

[192]

Dominant Deafness-Onychodystrophy syndrome

human

c.1516C > T mutation

[193]

cognitive deficits

ATPV1B2 mutant mice

weaker interaction with the V1E2E and abnormal brain development

[194]

ATP6AP2

X-linked mental retardation and epilepsy

human

impairment of ERK1/2 activation

[127]

X-linked Parkinson Disease

human

overexpression of a minor splice isoform due to mutation

[128]

cognitive impairment

ATP6AP2 conditional knockout Drosophila/mice

defects in presynaptic transmission and synapses abnormal caused by conditional knockout

[179]

ATP13A2

Neuronal ceroid lipofuscinosis

human

mutation

[195]

ATP13A2 ko mice

increased insoluble α-synuclein in the hippocampus

[196]

Kufor-Rakeb syndrome

ATP13A2 ko mice

increase in gliosis, lipofuscinosis and lysosomal markers; protein aggregation but no α-synuclein abnormalities; selective defects in autophagy

[197]

Hereditary parkinsonism

human/in vitro

retaintion in the endoplasmic reticulum and degradation by the proteasome due to truncation

[198]

WFS1

Wolfram Syndrome

human

mutation

[130]

WFS1−/− mice

V1A/V1B instability

[199]

CLN1

Neuronal ceroid lipofuscinoses

human

mutation

[139]

CLN1−/− mice

misrouting of V-ATPase subunit V0a

[141]